N
301277
vs
S
Shanghai Composite
Over the past 12 months, Newland Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +1% compared to the Shanghai Composite's +26% growth.
Stocks Performance
301277 vs Shanghai Composite
Performance Gap
301277 vs Shanghai Composite
Performance By Year
301277 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Newland Pharmaceutical Co Ltd
Glance View
Newland Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Xuchang, Henan and currently employs 800 full-time employees. The company went IPO on 2022-11-16. Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The firm's main business is the research and development, production and sales of pharmaceutical intermediates. The firm's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The firm also produces pharmaceutical resolution agents. The firm mainly operates its businesses in the domestic and overseas markets.
